9-115040992-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002160.4(TNC):c.5341G>A(p.Ala1781Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.039 in 1,613,834 control chromosomes in the GnomAD database, including 1,894 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.056 ( 338 hom., cov: 32)
Exomes 𝑓: 0.037 ( 1556 hom. )
Consequence
TNC
NM_002160.4 missense
NM_002160.4 missense
Scores
6
12
Clinical Significance
Conservation
PhyloP100: 2.52
Genes affected
TNC (HGNC:5318): (tenascin C) This gene encodes an extracellular matrix protein with a spatially and temporally restricted tissue distribution. This protein is homohexameric with disulfide-linked subunits, and contains multiple EGF-like and fibronectin type-III domains. It is implicated in guidance of migrating neurons as well as axons during development, synaptic plasticity, and neuronal regeneration. [provided by RefSeq, Jul 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0016574562).
BP6
Variant 9-115040992-C-T is Benign according to our data. Variant chr9-115040992-C-T is described in ClinVar as [Benign]. Clinvar id is 586835.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-115040992-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.103 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNC | NM_002160.4 | c.5341G>A | p.Ala1781Thr | missense_variant | 19/28 | ENST00000350763.9 | NP_002151.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNC | ENST00000350763.9 | c.5341G>A | p.Ala1781Thr | missense_variant | 19/28 | 1 | NM_002160.4 | ENSP00000265131.4 |
Frequencies
GnomAD3 genomes AF: 0.0559 AC: 8487AN: 151950Hom.: 339 Cov.: 32
GnomAD3 genomes
AF:
AC:
8487
AN:
151950
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0554 AC: 13933AN: 251304Hom.: 642 AF XY: 0.0493 AC XY: 6699AN XY: 135842
GnomAD3 exomes
AF:
AC:
13933
AN:
251304
Hom.:
AF XY:
AC XY:
6699
AN XY:
135842
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0372 AC: 54402AN: 1461766Hom.: 1556 Cov.: 34 AF XY: 0.0362 AC XY: 26351AN XY: 727190
GnomAD4 exome
AF:
AC:
54402
AN:
1461766
Hom.:
Cov.:
34
AF XY:
AC XY:
26351
AN XY:
727190
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0559 AC: 8506AN: 152068Hom.: 338 Cov.: 32 AF XY: 0.0572 AC XY: 4256AN XY: 74356
GnomAD4 genome
AF:
AC:
8506
AN:
152068
Hom.:
Cov.:
32
AF XY:
AC XY:
4256
AN XY:
74356
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
108
ALSPAC
AF:
AC:
105
ESP6500AA
AF:
AC:
400
ESP6500EA
AF:
AC:
266
ExAC
AF:
AC:
6255
Asia WGS
AF:
AC:
237
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 12, 2018 | This variant is associated with the following publications: (PMID: 16741161) - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 24, 2018 | - - |
Autosomal dominant nonsyndromic hearing loss 56 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Mar 15, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;.;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;.
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;.;.;.;.
PrimateAI
Benign
T
PROVEAN
Benign
.;N;N;N;N;N
REVEL
Benign
Sift
Benign
.;T;D;D;D;D
Sift4G
Benign
T;D;T;T;T;T
Polyphen
0.95, 0.99
.;P;.;D;.;.
Vest4
MPC
0.49
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at